Dysregulated AKT1 signaling contributes to neuroinflammatory processes and insulin resistance, key mechanisms linking AD and T2DM (El Idrissi et al. 2021; Liao and Xu 2009; Arous et al. 2020). The gene discussed is AKT1; the disease is Alzheimer disease.